Advertisement

Topics

ReproCELL, Inc. Company Profile

19:18 EDT 22nd September 2018 | BioPortfolio

“ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in December this year. Read on for details.


News Articles [6 Associated News Articles listed on BioPortfolio]

Q Therapeutics, ReproCELL form MAGiQ, a CNS diseases JV

Fellow cell therapy companies Q Therapeutics Inc. and ReproCELL Inc. formed a 50/50-owned CNS disease-focused joint venture, which will be headquartered in Japan and known as MAGiQ Therapeutics Inc. R...

M&As this week: RxCelerate, HealthCare Global Enterprises, REPROCELL

RxCelerate Ltd has acquired Total Scientific Ltd, a contract research organisation. The Total Scientific brand will be withdrawn and the...Read More... The post M&As this week: RxCelerate, HealthC...

Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

New headquarters strengthen drug discovery services and translational research, and generate new employment opportunities in Scotland.Glasgow, UK. 10th August 2017: REPROCELL Europe Ltd (REPROCELL), a...

Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

To treat demyelinating and degenerative diseases of the CNS

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products through its divisions such as research reagents, cultivat...

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products through its divisions such as research reagents, cultivat...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ReproCELL Inc.

ReproCELL, Inc.

“ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in Decem...

More Information about "ReproCELL, Inc." on BioPortfolio

We have published hundreds of ReproCELL, Inc. news stories on BioPortfolio along with dozens of ReproCELL, Inc. Clinical Trials and PubMed Articles about ReproCELL, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReproCELL, Inc. Companies in our database. You can also find out about relevant ReproCELL, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record